Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-08-22

Clinical Trial Update: Mupirocin 2% Ointment Vs Spray Antibiotics on Temporary Hemodialysis Catheter [Phase 2, Phase 3]

View source ↗

Summary

A phase 2/3 clinical trial comparing mupirocin 2% ointment versus mupirocin spray for preventing infections in temporary hemodialysis catheters has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mupirocin 2% Ointment (mupirocin)
  • Mupirocin spray (mupirocin)

Snippet

Sponsor: Future University in Egypt | Conditions: Hemodialysis Complication, Hemodialysis Catheter Infection | Phase 2, Phase 3 | Status: COMPLETED